These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 14330876
1. THE FORMULATION AND MANUFACTURING OF STERILE PHARMACEUTICAL PRODUCTS. KIRSCH NC. Pharm Weekbl; 1965 Mar 26; 100():413-28. PubMed ID: 14330876 [No Abstract] [Full Text] [Related]
2. Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future. Allen LV. Int J Pharm Compd; 2017 Mar 26; 21(4):293-298. PubMed ID: 28719372 [Abstract] [Full Text] [Related]
3. Basics of Sterile Compounding: Excipients Used in Injections. Akers MJ. Int J Pharm Compd; 2017 Mar 26; 21(4):301-308. PubMed ID: 28719373 [Abstract] [Full Text] [Related]
4. Basics of sterile compounding: unique and special characteristics of sterile dosage forms. Akers MJ. Int J Pharm Compd; 2014 Mar 26; 18(6):479-84. PubMed ID: 25906625 [Abstract] [Full Text] [Related]
5. Design and operation of a new sterile manufacturing facility. Fornabaio TA. Bull Parenter Drug Assoc; 1970 Mar 26; 24(3):110-8. PubMed ID: 5422900 [No Abstract] [Full Text] [Related]
6. Increasing Patient Safety by Closing the Sterile Production Gap-Part 1. Introduction. Agalloco JP. PDA J Pharm Sci Technol; 2017 Mar 26; 71(4):261-268. PubMed ID: 28089964 [Abstract] [Full Text] [Related]
7. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles]. Witschi T. Pharm Acta Helv; 1973 Feb 26; 48(2):53-62. PubMed ID: 4706309 [No Abstract] [Full Text] [Related]
8. Increasing Patient Safety by Closing the Sterile Production Gap-Part 2. Implementation. Agalloco JP. PDA J Pharm Sci Technol; 2017 Feb 26; 71(4):269-273. PubMed ID: 28089965 [Abstract] [Full Text] [Related]
11. Development and evaluation of a laboratory-scale apparatus to simulate the scale-up of a sterile semisolid and effects of manufacturing parameters on product viscosity. Chu PI, Doyle D. Pharm Dev Technol; 1999 Feb 26; 4(4):553-9. PubMed ID: 10578510 [Abstract] [Full Text] [Related]
12. High throughput formulation: strategies for rapid development of stable protein products. Nayar R, Manning MC. Pharm Biotechnol; 2002 Feb 26; 13():177-98. PubMed ID: 11987752 [No Abstract] [Full Text] [Related]
15. [ON THE VALUE AND TESTING OF DRUGS]. BUECHI J. Pharm Acta Helv; 1964 Feb 26; 39():65-76. PubMed ID: 14224305 [No Abstract] [Full Text] [Related]
16. [Practical realization of manufacturing control in Switzerland]. Witschi T. Pharm Acta Helv; 1972 Feb 26; 47(11):637-47. PubMed ID: 4657533 [No Abstract] [Full Text] [Related]
17. A new definition of pharmaceutical quality: assembly of a risk simulation platform to investigate the impact of manufacturing/product variability on clinical performance. Short SM, Cogdill RP, D'Amico F, Drennen JK, Anderson CA. J Pharm Sci; 2010 Dec 26; 99(12):5046-59. PubMed ID: 20574996 [Abstract] [Full Text] [Related]
18. BASICS OF STERILE COMPOUNDING: Sterilization Methods in Sterile Product Manufacturing. Akers MJ. Int J Pharm Compd; 2015 Dec 26; 19(2):127-38. PubMed ID: 26685494 [Abstract] [Full Text] [Related]
20. [Microbiologic validation in the production of sterile pharmaceuticals]. Pongiluppi S. Boll Chim Farm; 1991 Jun 26; 130(6):203-12. PubMed ID: 1756004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]